These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7416734

  • 1. [Effect of polyene antibiotics on the increase in specific resistance due to inactivated antiviral vaccines].
    Vil'ner LM, Ral'f NM, Finogenova EV, Shneĭder MA, Tereshin IM.
    Antibiotiki; 1980 Sep; 25(9):669-73. PubMed ID: 7416734
    [Abstract] [Full Text] [Related]

  • 2. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA, Shtil'bans EB, Paleĭ EI, Vil'ner LM, Tereshin IM.
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [Abstract] [Full Text] [Related]

  • 3. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis].
    Fomina AN, Nosik NN, Bukata LA, Davydova AA, Barinskiĭ NF.
    Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497
    [Abstract] [Full Text] [Related]

  • 4. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.
    J Infect Dis; 2003 Oct 15; 188(8):1213-30. PubMed ID: 14551893
    [Abstract] [Full Text] [Related]

  • 5. [Immunogenicity and protective properties for mice of the formalin-inactivated tick-borne encephalitis virus].
    Gut W, Jarzabek Z, Sadowski W, Kańtoch M.
    Med Dosw Mikrobiol; 1986 Oct 15; 38(4):234-40. PubMed ID: 3561097
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C, Custer D, VanderZanden L, Spik K, Rossi C, Bray M.
    Virology; 1999 Oct 10; 263(1):166-74. PubMed ID: 10544091
    [Abstract] [Full Text] [Related]

  • 7. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C, Shi H, Zhou J, Liang Y, Xu H.
    Vaccine; 2009 Nov 05; 27(47):6558-63. PubMed ID: 19729087
    [Abstract] [Full Text] [Related]

  • 8. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E, Yamaoka M, Kurane I, Mason PW.
    Virology; 2000 Mar 01; 268(1):49-55. PubMed ID: 10683326
    [Abstract] [Full Text] [Related]

  • 9. [Trypanosome sensitivity to polyene antibiotics].
    Chuenkova MV, Sukhareva NN, Liubimova LK, Egorov NS.
    Antibiotiki; 1982 Jun 01; 27(6):424-30. PubMed ID: 7051969
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 11. [Mathematical model of zone formation taking into account the inactivation of polyene antibiotics diffusing into an inoculated gel].
    Mitintskiĭ AB, Fradkova TA, Poliak MS.
    Antibiotiki; 1981 Sep 25; 26(9):676-80. PubMed ID: 7294759
    [Abstract] [Full Text] [Related]

  • 12. Antibody response of kori bustards (Ardeotis kori) and houbara bustards (Chlamydotis undulata) to live and inactivated Newcastle disease vaccines.
    Bailey TA, Wernery U, Samour JH, Naldo JL.
    J Zoo Wildl Med; 1998 Dec 25; 29(4):441-50. PubMed ID: 10065854
    [Abstract] [Full Text] [Related]

  • 13. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models.
    Shams H, Heron I.
    Biologicals; 1999 Sep 25; 27(3):227-40. PubMed ID: 10652178
    [Abstract] [Full Text] [Related]

  • 14. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.
    Acta Paediatr; 1999 May 25; 88(5):513-20. PubMed ID: 10426173
    [Abstract] [Full Text] [Related]

  • 15. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H.
    Verh K Acad Geneeskd Belg; 2000 May 25; 62(4):245-67. PubMed ID: 11004905
    [Abstract] [Full Text] [Related]

  • 16. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA, Bogdan JR, Kanara EW, Morley PS, Haines DM.
    J Am Vet Med Assoc; 1995 Mar 15; 206(6):823-32. PubMed ID: 7538990
    [Abstract] [Full Text] [Related]

  • 17. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V, Bianco V, Fondevila N, Pappalardo S, Sadir A, Zamorano P.
    Dev Biol (Basel); 2004 Mar 15; 119():481-97. PubMed ID: 15742663
    [Abstract] [Full Text] [Related]

  • 18. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF.
    Virology; 1997 Dec 22; 239(2):389-401. PubMed ID: 9434729
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B, Dobrovsak-Sourek V, Kaić B, Ljubicić M.
    Acta Med Croatica; 1998 Dec 22; 52(3):155-8. PubMed ID: 9818437
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM.
    J Infect Dis; 2004 Oct 15; 190(8):1404-12. PubMed ID: 15378432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.